These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

836 related items for PubMed ID: 21557766

  • 21. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD, Leung CH, Yan B, Tan CM, Low SY, Aung MO, Salto-Tellez M, Lim SG, Hooi SC.
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
    Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, Lee YS, Yen TC, Hsieh SY.
    J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [Abstract] [Full Text] [Related]

  • 24. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H, Nagano H, Yamamoto H, Yang Y, Kondo M, Ota H, Nakamura M, Yoshioka S, Kato H, Damdinsuren B, Tang D, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Sakon M, Dono K, Wakasa K, Monden M.
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [Abstract] [Full Text] [Related]

  • 25. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
    El Tayebi HM, Hosny KA, Esmat G, Breuhahn K, Abdelaziz AI.
    FEBS Lett; 2012 Sep 21; 586(19):3309-16. PubMed ID: 22819824
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
    Li Q, Wang G, Zhang ZM.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan 21; 17(1):42-5. PubMed ID: 19203451
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.
    Cancer Res; 2009 Jul 15; 69(14):5761-7. PubMed ID: 19584283
    [Abstract] [Full Text] [Related]

  • 32. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
    Gramantieri L, Chieco P, Giovannini C, Lacchini M, Treré D, Grazi GL, Venturi A, Bolondi L.
    Hum Pathol; 2005 Nov 15; 36(11):1154-62. PubMed ID: 16260267
    [Abstract] [Full Text] [Related]

  • 33. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.
    J Hepatol; 2015 Oct 15; 63(4):874-85. PubMed ID: 25998163
    [Abstract] [Full Text] [Related]

  • 34. Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells.
    Nakada C, Tsukamoto Y, Matsuura K, Nguyen TL, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.
    J Pathol; 2011 Jun 15; 224(2):280-8. PubMed ID: 21465485
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS.
    World J Gastroenterol; 2016 Jun 21; 22(23):5364-73. PubMed ID: 27340352
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L, Cai X.
    Diagn Pathol; 2014 Dec 31; 9():1000. PubMed ID: 25552204
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.